Cellestia Biotech AG
PrivateLast Round
Grant
Jan 22, 2024
Total Funding Raised
$51.9M
Company Overview
Cellestia Biotech AG operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Grant round in January 2024.
Cellestia Biotech AG is a biopharmaceutical company that develops first-in-class targeted therapeutics for the treatment of oncology and immunological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellestia Biotech AG Comparables
Compare Cellestia Biotech AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StemSynergy Therapeutics, Inc. | 85% | |
| Mereo BioPharma Group plc | 77% | |
| Immunome, Inc. | 77% |
For institutional investors. Book with your work email.
Cellestia Biotech AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2024 | ||||
| VC Round | Aug 17, 2021 | ||||
| Series B | Dec 17, 2019 | ||||
| Series A | Dec 19, 2018 | ||||
| Seed | Jan 26, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellestia Biotech AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sotio | Series A |
| SNGLR Capital | VC Round |
| PPF Group | Series B, Seed |
| Partners Investment | Series B |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2024
$2.3M grant received from Innosuisse.
- Aug 17, 2021
SNGLR Capital participated in the round.
For institutional investors. Book with your work email.
Cellestia Biotech AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellestia Biotech AG's valuation, stock price, and market status.
Is Cellestia Biotech AG a public or private company?
Cellestia Biotech AG is a private company.
What is the current stock price of Cellestia Biotech AG?
Cellestia Biotech AG is a private company, so its shares have no public market price. Caplight tracks Cellestia Biotech AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellestia Biotech AG worth (valuation)?
Valuation information for Cellestia Biotech AG is not publicly available.
Can I buy Cellestia Biotech AG stock?
Cellestia Biotech AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellestia Biotech AG's last funding round?
Cellestia Biotech AG's most recent funding round was Grant on January 22, 2024.
Who are the main investors in Cellestia Biotech AG?
Key investors in Cellestia Biotech AG include Sotio.
Will Cellestia Biotech AG IPO soon?
No public IPO plans have been announced for Cellestia Biotech AG.
How can I track Cellestia Biotech AG secondary market activity?
Caplight tracks bids, offers, and trades in Cellestia Biotech AG's shares on secondary markets.